METHODS	In this double-blind , placebo-controlled , randomized , parallel-group , dose-response study , 270 patients with idiopathic RLS were enrolled and randomized to receive sumanirole 0.5 , 1.0 , 2.0 , or 4.0 mg , or placebo .\